Cullen Frost Bankers Inc. Buys 887 Shares of Synopsys, Inc. $SNPS

Cullen Frost Bankers Inc. grew its stake in shares of Synopsys, Inc. (NASDAQ:SNPSFree Report) by 5.6% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 16,642 shares of the semiconductor company’s stock after purchasing an additional 887 shares during the period. Cullen Frost Bankers Inc.’s holdings in Synopsys were worth $8,532,000 as of its most recent SEC filing.

Other large investors have also recently modified their holdings of the company. HBW Advisory Services LLC boosted its stake in shares of Synopsys by 494.9% during the 2nd quarter. HBW Advisory Services LLC now owns 3,611 shares of the semiconductor company’s stock valued at $1,851,000 after purchasing an additional 3,004 shares in the last quarter. Westbourne Investments Inc. bought a new stake in shares of Synopsys during the 2nd quarter valued at about $1,505,000. Bourgeon Capital Management LLC bought a new stake in shares of Synopsys during the 2nd quarter valued at about $451,000. North Star Asset Management Inc. boosted its stake in shares of Synopsys by 3.6% during the 1st quarter. North Star Asset Management Inc. now owns 60,270 shares of the semiconductor company’s stock valued at $25,847,000 after purchasing an additional 2,082 shares in the last quarter. Finally, SlateStone Wealth LLC boosted its stake in shares of Synopsys by 467.8% during the 1st quarter. SlateStone Wealth LLC now owns 10,220 shares of the semiconductor company’s stock valued at $4,383,000 after purchasing an additional 8,420 shares in the last quarter. Institutional investors own 85.47% of the company’s stock.

Insider Activity

In related news, Director Robert G. Painter purchased 350 shares of Synopsys stock in a transaction dated Thursday, September 11th. The stock was purchased at an average cost of $425.44 per share, for a total transaction of $148,904.00. Following the completion of the purchase, the director directly owned 2,291 shares of the company’s stock, valued at $974,683.04. The trade was a 18.03% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, CAO Sudhindra Kankanwadi sold 9,873 shares of Synopsys stock in a transaction that occurred on Monday, September 22nd. The stock was sold at an average price of $500.90, for a total transaction of $4,945,385.70. Following the completion of the sale, the chief accounting officer owned 20,520 shares of the company’s stock, valued at $10,278,468. This represents a 32.48% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 30,894 shares of company stock valued at $16,760,783 over the last ninety days. 0.62% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on SNPS shares. Wall Street Zen cut shares of Synopsys from a “hold” rating to a “sell” rating in a research report on Saturday, September 13th. Piper Sandler lowered their price target on shares of Synopsys from $660.00 to $630.00 and set an “overweight” rating for the company in a research report on Wednesday, September 10th. Citigroup cut shares of Synopsys from a “neutral” rating to an “underperform” rating in a research report on Wednesday, September 10th. Zacks Research cut shares of Synopsys from a “hold” rating to a “strong sell” rating in a research report on Friday, September 12th. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Synopsys in a research report on Wednesday, October 8th. Ten analysts have rated the stock with a Buy rating, five have assigned a Hold rating and four have assigned a Sell rating to the company. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $569.67.

Get Our Latest Analysis on Synopsys

Synopsys Stock Down 1.0%

Shares of Synopsys stock opened at $454.30 on Thursday. The company has a debt-to-equity ratio of 0.52, a quick ratio of 1.51 and a current ratio of 1.62. The stock has a market capitalization of $84.39 billion, a PE ratio of 35.66, a price-to-earnings-growth ratio of 5.06 and a beta of 1.10. Synopsys, Inc. has a 52-week low of $365.74 and a 52-week high of $651.73. The company has a 50-day simple moving average of $515.84 and a two-hundred day simple moving average of $511.08.

Synopsys (NASDAQ:SNPSGet Free Report) last issued its earnings results on Tuesday, September 9th. The semiconductor company reported $2.30 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.75 by ($1.45). The firm had revenue of $1.74 billion during the quarter, compared to analysts’ expectations of $1.77 billion. Synopsys had a return on equity of 10.82% and a net margin of 31.04%.The firm’s quarterly revenue was up 14.0% on a year-over-year basis. During the same period last year, the firm posted $3.43 earnings per share. Synopsys has set its FY 2025 guidance at 12.760-12.800 EPS. Q4 2025 guidance at 2.760-2.80 EPS. On average, analysts anticipate that Synopsys, Inc. will post 10.64 EPS for the current fiscal year.

Synopsys Company Profile

(Free Report)

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.

See Also

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPSFree Report).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.